Package leaflet: Information for the user
Burana 800 mg film-coated tablet (tablet)
Ibuprofen
Read all of this leaflet carefully before you start using this medicine because it contains important
information for you.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if
their signs of illness are the same as yours.
If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects
not listed in this leaflet.
What is in this leaflet:
1.
What Burana is and what it is used for
2.
What you need to know before you use Burana
3.
How to use Burana
4.
Possible side effects
5.
How to store Burana
6.
Contents of the pack and other information
1.
What Burana is and what it is used for
Burana belongs to a group of medicinal products named NSAID (non-steroidal anti-inflammatory drugs).
Burana reduces fever and has a pain-relieving and anti-inflammatory effect. The effect is achieved usually in
30 minutes and the maximal effect in 1-2 hours.
Burana 200 mg and 400 mg tablets are used for acute painful conditions of mild to moderate intensity like
headache, toothache, back pain, muscle- and joint pain, fever associated with upper respiratory tract
infection (e.g. common cold) and menstrual pains. Burana 400 mg, 600 mg and 800 mg are used for
symptomatic treatment of pain and inflammation in rheumatic conditions (rheumatoid arthritis and
osteoarthritis) in adults.
2.
What you need to know before you use Burana
Do not use Burana
if you are allergic to ibuprofen or any of the other ingredients of this medicine (listed in section 6)
if you have experienced allergic reactions like asthma, rhinitis, or urticaria with intake of painrelieving drugs containing acetylsalicylic acid or certain other anti-inflammatory drugs (NSAIDs)
if you have increased risk for bleeding
if you have gastric or duodenal ulcer or have had recurrent gastric or duodenal ulcer (two or more
distinct episodes of proven ulceration or bleeding)
if you have experienced gastrointestinal bleeding or ulceration related to treatment with NSAIDs
if you have severe hepatic failure
if you have severe heart failure or severe impaired renal function
if you are in the last three months of pregnancy.
Warnings and precautions
Talk to your doctor or pharmacist before using Burana if
1
-
you have kidney or liver disease
you have heart failure
you have hypertension
you have asthma or an allergic disease
you have SLE (Systemic lupus erythematosus) a collagen disease
you have had gastric or duodenal ulcer or other gastrointestinal conditions (like ulcerative colitis,
Crohn’s disease)
you have a disease associated with increased tendency for bleeding
you are suffering from significant dehydration (caused by vomiting, diarrhoea or insufficient fluid
intake).
Consult your doctor before taking Burana if you are pregnant or are planning a pregnancy. See also section
“Pregnancy, breast-feeding and fertility”.
Elderly people should be aware of their increased risk of adverse events, especially bleeding and perforation
in the digestive tract, which may be fatal.
If you have earlier had an ulcer in the stomach or intestines, especially if this has been complicated by
perforation or accompanied by bleeding, you should look out for any unusual symptoms in the abdomen, and
report them at once to your doctor. Bleeding, ulceration or perforation in the stomach or intestines may
occur without any warning signs even in patients who have never had such problems before. If bleeding or
ulceration of the digestive tract occurs, the treatment has to be stopped.
In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders there may be an
increased risk of aseptic meningitis.
The lowest effective dose should always be used to minimize the risk for adverse events. Using a higher
dose than recommended may increase the risk for adverse events.
Stop taking Burana and contact immediately your doctor if you experience swelling of among others face,
tongue, and/or throat or nettle-rash, shortness in breath and difficulty in swallowing (angiooedema).
Serious skin reactions have been reported very rarely in association with the use of NSAIDs. Stop taking
Burana and contact a doctor if you get skin reactions or mucosal lesions.
During varicella it is advisable to avoid use of this drug.
Medicinal products like Burana may involve a small increased risk of myocardial infarction or stroke. This
small increased risk is more likely at high dosages and in long term treatment.
Ask your doctor or pharmacist for advice about your treatment if you have any heart disease, if you earlier
have had stroke or if you believe you have an increased risk for these conditions (e.g. if you have
hypertension, diabetes, high cholesterole values or if you are smoking).
Other medicines and Burana
Do not use simultaneously other pain-killers, including other NSAIDs, without first consulting a doctor or
pharmacist.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines.
The effect of the following medicines may change or the effect of Burana may change in concomitant use:
acetylsalicylic acid (drugs against pain and fever, and in small doses to prevent blood clots)
warfarin, ticlopidin (certain drugs for blood clots)
methotrexate (drugs for cancer and immune system disturbances)
2
-
antihypertensive drugs like beta blockers, diuretics (thiazides, furosemide, bumetanide), ACE
inhibitors (e.g. captopril) and angiotensin II-antagonists (e.g. losartan)
cyclosporin, tacrolimus (drugs that prevent transplant rejection)
lithium (drugs for manic-depressive illness)
selective serotonin reuptake inhibitors (so called SSRIs, e.g. paroxetine, sertraline, citalopram against
depression)
corticosteroids (anti-inflammatory drugs)
aminoglycosides (certain antibiotics)
voriconazole and fluconazole (drugs that treat fungal infections)
colestyramine (cholesterol medicine)
digoxin (heart medicine)
sulphonylureas (diabetes medicines)
zidovudine (drugs for HIV infection).
Consult a doctor before using Burana if you use any above mentioned medicine.
Pregnancy, breast-feeding and fertility
Pregnancy
Pregnant women should not use Burana in the last three months of pregnancy. Intake of Burana should be
avoided by women who plan pregnancy or are pregnant. Treatment during any part of pregnancy should take
place only by doctor’s order.
Breast-feeding
Ibuprofen is excreted in breast milk but is not likely to have an effect on the infant. Consult a doctor if you
use Burana more often than temporarily while breastfeeding.
Fertility
Use of Burana may temporarily make it more difficult to become pregnant and therefore treatment is not
recommended to women who try to get pregnant. This effect is reversible, when you stop taking the
medicine.
Driving and using machines
Treatment with Burana may cause visual disturbances as an adverse effect. These effects are uncommon, but
must be kept in mind when sharp attention is needed, e.g. when driving a car.
Burana contains sucrose and lactose monohydrate. If you have been told by your doctor that you have an
intolerance to some sugars, contact your doctor before taking this medicinal product.
3.
How to use Burana
Your doctor will adjust the correct dose individually for you. Always take this medicine exactly as your
doctor has told you. Check with your doctor or pharmacist if you are not sure.
Burana tablets 400 mg
Mild to moderate acute painful conditions and fever associated with upper respiratory tract infection (e.g.
common cold).
The recommended dose for adults and children over 12 years:
200-400 mg as a single dose or 3-4 times daily (at least 4 hours between doses), however maximal daily
dose is 1200 mg. Single doses over 400 mg do not give any better pain-relieving effect.
Menstrual pain.
3
The usual dose for adults and children over 12 years: 400 mg 1-3 times daily (at least 4 hours between
doses) when needed. Start taking medicine as soon as menstruation begins to have a better effect.
Burana tablets 400 mg, 600 mg and 800 mg
Rheumatic diseases.
The recommended dose for adults: 400 mg - 600 mg three times daily. A maintenance dose of 600-1200 mg
daily could be effective for some patients. In acute and severe conditions the dose could be increased to a
maximum of 2400 mg divided in 3-4 doses. To the faster relief of early morning stiffness the first dose can
be taken on an empty stomach.
Elderly
If you are elderly you should always consult your doctor before using Burana since you will be more prone
to side effects, especially bleeding and perforation in the digestive tract, which may be fatal. Your doctor
will advise you accordingly.
Reduced kidney or liver function
If you suffer from reduced kidney or liver function, always consult your doctor before using Burana. Your
doctor will advise you accordingly.
The tablet can be divided into equal doses.
If you use more Burana than you should
If you have taken a too large dose or if a child has taken Burana by mistake, always contact a doctor or
hospital for advice.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4.
Possible side effects
Like all medicines, Burana can cause side effects, although not everybody gets them.
Common (occurs in more than 1 out of 100 users): Gastrointestinal side-effects (dyspepsia, abdominal pain,
diarrhoea, constipation, nausea, vomiting). Tiredness, headache. Eczema. Gastrointestinal problems usually
decreases if you take Burana together with food.
Uncommon (occurs in less than 1 out of 100 users): Asthma, itching, nettle-rash, purpura, rhinitis, insomnia,
mild anxiety. Hearing and vision disturbances, that disappear when treatment is stopped. Swelling of
mucous membranes in mouth and throat (angiooedema). Gastric and intestinal hemorrhages, gastric ulcer.
Rare (occurs in less than 1 out of 1000 users): Fluid retention (oedema). Change in blood composition
(leucopenia, thrombocytopenia, aplastic anaemia). Heart failure, hypertension. Ulcerative colitis,
pancreatitis, perforations, black faeces, flatulence, vomiting of blood, impairment of ulcerous colitis, and
Crohn’s disease. Aseptic meningitis, dizziness, inflammation of optic nerve. Anaphylactic reactions
(hypersensitive reactions with fever, eczema, oedema and hypotension), liver and kidney effects, skin
reactions like in Stevens-Johnsons syndrome, epidermolysis (occasionally serious), erythema, sensitivity to
light, hair loss. Depression, confusion, poor vision, ringing in the ears.
Exceptional serious infections of the skin in case of varicella.
Medicinal products like Burana may involve a small increased risk of myocardial infarction or stroke.
4
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell
your doctor or pharmacist.
5.
How to store Burana
Keep this medicine out of the sight and reach of children.
PVC/Al blister: Store below 30°C.
HDPE jar: This medicinal product does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers
to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw
away medicines you no longer require. These measures will help protect the environment.
6.
Contents of the pack and other information
What Burana contains
-
The active substance is ibuprofen. .
The other ingredients in the tablet core are lactose monohydrate, gelatin, macrogol, colloidal
anhydrous silica, croscarmellose sodium and microcristalline cellulose. The other ingredients in the
film coating are sucrose, hypromellose, polysorbate 80, titanium dioxide (E 171), glycerol (85%) and
magnesium stearate.
What Burana looks like and contents of the pack
Film-coated tablet (tablet).
White or almost white, film-coated capsule formed tablet, 20 x 10 mm, scored.
The tablets can be divided into equal halves,
Pack sizes:
PVC/Al blister: 10, 20, 30 and 50 tablets.
HDPE jar with HDPE screw cap: 100 tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Orion Corporation
Orionintie 1
FI-02200 Espoo
Finland
Manufacturer
Orion Corporation Orion Pharma
Orionintie 1
FI-02200 Espoo
5
Finland
This medicinal product is authorised in the Member States of the EEA under the following names:
Czech Republic: Iburion
Denmark: Burana
Norway: Burana
Poland: Iburion
Slovakia: Iburion
Sweden: Burana
This leaflet was last revised in 2012-05-25
6